Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Weyenberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
The effect of HPβCD on Cyclosporine A in-vitro release from PLGA nanoparticlesKris Hermans, Wim Weyenberg, Annick Ludwig
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 29, 2004
The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticlesKathleen Dillen, Wim Weyenberg, Jo Vandervoort, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2003
Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humansMargit Hornof, Wim Weyenberg, Annick Ludwig, et al.
Osteoarthritis and Cartilage Open|April 18, 2025
Twelve-month efficacy of carboxymethyl-chitosan in refractory knee osteoarthritis: A randomized controlled trial (PIONEER)Philippe Van Overschelde, Pieter Vansintjan, Nicolas Portelange, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitabletsWim Weyenberg, An Vermeire, Jo Vandervoort, et al.
Rheumatology and Therapy|March 18, 2024
Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in GermanyNils A Lynen, Christoph Eichhorn, Nicolas Portelange, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 29, 2012
Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticlesKris Hermans, Dave Van den Plas, Arnout Everaert, et al.
Nature Reviews. Drug Discovery|December 2, 2009
TelavancinG Ralph Corey, Martin E Stryjewski, Wim Weyenberg, et al.
International Journal of Pharmaceutics|January 28, 2015
Evaluation of a newly developed HPMC ophthalmic insert with sustained release properties as a carrier for thermolabile therapeuticsArnout Everaert, Géraldine Broeckx, Erik Fransen, et al.
International Journal of Pharmaceutics|June 19, 2017
Optimisation of HPMC ophthalmic inserts with sustained release properties as a carrier for thermolabile therapeuticsArnout Everaert, Yannick Wouters, Eline Melsbach, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
The effect of HPβCD on Cyclosporine A in-vitro release from PLGA nanoparticlesKris Hermans, Wim Weyenberg, Annick Ludwig
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 29, 2004
The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticlesKathleen Dillen, Wim Weyenberg, Jo Vandervoort, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2003
Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humansMargit Hornof, Wim Weyenberg, Annick Ludwig, et al.
Osteoarthritis and Cartilage Open|April 18, 2025
Twelve-month efficacy of carboxymethyl-chitosan in refractory knee osteoarthritis: A randomized controlled trial (PIONEER)Philippe Van Overschelde, Pieter Vansintjan, Nicolas Portelange, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitabletsWim Weyenberg, An Vermeire, Jo Vandervoort, et al.
Rheumatology and Therapy|March 18, 2024
Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in GermanyNils A Lynen, Christoph Eichhorn, Nicolas Portelange, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 29, 2012
Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticlesKris Hermans, Dave Van den Plas, Arnout Everaert, et al.
Nature Reviews. Drug Discovery|December 2, 2009
TelavancinG Ralph Corey, Martin E Stryjewski, Wim Weyenberg, et al.
International Journal of Pharmaceutics|January 28, 2015
Evaluation of a newly developed HPMC ophthalmic insert with sustained release properties as a carrier for thermolabile therapeuticsArnout Everaert, Géraldine Broeckx, Erik Fransen, et al.
International Journal of Pharmaceutics|June 19, 2017
Optimisation of HPMC ophthalmic inserts with sustained release properties as a carrier for thermolabile therapeuticsArnout Everaert, Yannick Wouters, Eline Melsbach, et al.
Pageof 2